Dose-response relationship in phase I clinical trials: A European Drug Development Network (EDDN) collaboration study.

3084 Background: Alkylating agents have a strong dose effect relationship and this concept is used for development of novel cytotoxic (CTX) drugs. However, the need to reach MTD to obtain optimal b...